Genedrive plc

Company Profile

Company website
Pharmaceuticals and Biotechnology (Biotechnology)

Genedrive plc is a molecular diagnostics company developing and commercialising a low cost, rapid, versatile, simple to use and robust point of need molecular diagnostics platform for the diagnosis of infectious diseases and for use in patient stratification (genotyping), pathogen detection and other indications.

The Company has assays on the market for the detection of MT-RNR1, HCV, certain military biological targets, a high throughput SARS-CoV-2 assay and a point of care test for Covid-19.

The company are currently developing a genetic test for CYP2C19 metaboliser status.

Investor Access

05 Apr
Event information

The Company will be announcing its interim results for the six months ended 31 December 2023 on 28 March 2024.

The Company will provide a live presentation on Friday, 5 April 2024.

Investors can sign up to Investor Meet Company for free and add to meet genedrive plc:

Friday 5 April 2024 at 10am

Financial Calendar
 Event Date
Year End30 June
Half  Year End31 December
Preliminary ResultsNovember
Interim Results*March

* Months based on previous announcements of this kind